Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OPKO Health has signed a definitive agreement to acquire ALS Distribuidora Limitada, a privately-held Chilean pharmaceutical company.
Subscribe to our email newsletter
OPKO will acquire ALS for $4m in an all cash transaction from Inversiones SVJV, Inversiones BS and Inversiones PYTT.
ALS is an exclusive product distributor of Arama Laboratorios.
As a part of the transaction, OPKO will also acquire all of the product registrations and trademarks previously owned by Arama, as well as the Arama name.
OPKO chairman and CEO Phillip Frost said the acquisition is an excellent strategic fit as OPKO expands its sales and distribution capabilities, particularly for its new pharmaceutical and diagnostic products.